Results 251 to 260 of about 271,261 (306)

Can We Enhance Long Term Respiratory Outcomes of Neonatal Pulmonary Diseases? [PDF]

Pediatr Pulmonol
Kugelman A.
europepmc   +1 more source

Endocrinology and the Lung: Exploring the Bidirectional Axis and Future Directions. [PDF]

J Clin Med
Iglesias P.
europepmc   +1 more source

A Breath of Fresh Insight: Targeting CXCR4 in Early Chronic Obstructive Pulmonary Disease. [PDF]

Am J Respir Cell Mol Biol
Bignold RE, Johnson JR.
europepmc   +1 more source

Interaction between genetic predisposition to successful ageing and chronic air pollution on lung disease in elderly women: results of the German SALIA cohort. [PDF]

BMJ Open Respir Res
Kress S, Lau M, Wigmann C, Abramson MJ, Schwender H, Schikowski T.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lung Transplantation for Obstructive Lung Diseases

Seminars in Respiratory and Critical Care Medicine, 2013
Chronic obstructive pulmonary disease (COPD) represents one of the most common indications for lung transplantation, accounting for approximately one third of all procedures performed worldwide to date. Despite this extensive experience, questions remain about the appropriate timing of transplantation in the natural history of COPD, the optimal ...
Rupal J, Shah, Robert M, Kotloff
openaire   +2 more sources

OBSTRUCTIVE LUNG DISEASE AND SLEEP

Medical Clinics of North America, 1996
There is a significant interaction between obstructive lung disease and sleep--sleep is associated with clinical deterioration in obstructive lung disease, and vice versa. Knowledge of the pathophysiology of deterioration in obstructive lung disease during sleep is essential to the understanding of the management of this problem. Recent information has
R, Jokic, M F, Fitzpatrick
openaire   +2 more sources

Seretide for obstructive lung disease

Expert Opinion on Pharmacotherapy, 2002
Seretide (Advair [North America], GlaxoSmithKline) is an inhaler combination formulation intended for the maintenance therapy of obstructive airways disease. Seretide was developed and made available initially as three multi-dose, dry powder inhaler formulations delivering 50 microg/puff of the long acting beta(2) agonist salmeterol and either 100, 250
openaire   +2 more sources

Obstructive Lung Disease

1989
Obstructive lung disease like chronic bronchitis, asthma, pulmonary emphysema and their numerous combinations result from acute or chronic influence of noxious factors on the structures of the respiratory system. While in chronic bronchitis and asthma the conducting airways are affected, in pulmonary emphysema the integrity of the pulmonary parenchyma ...
openaire   +2 more sources

Obstructive Lung Disease

2023
Abstract Obstructive airway diseases are a commonly tested topic in anesthesia for both the written and oral examinations and are separated into upper airway (obstructive sleep apnea [OSA]), tracheobronchial (foreign body), and parenchymal disorders (mediastinal masses). Obstructive disorders have resistance to airflow which leads to air
Bryan J. Hierlmeier, Anesh Rugnath
openaire   +1 more source

Pulmonary Hemodynamics in Obstructive Lung Disease

Diseases of the Chest, 1968
SUMMARY Various aspects of pulmonary hemodynamics were studied in 34 emphysema patients: (a) when the cardiac output was interpreted on the basis of each patient's age, the majority (85 per cent) showed either normal or high output, while the remainder (15 per cent) had a definitely low output.
T P, Lim, W E, Brownlee
openaire   +2 more sources